Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands

Abstract Background Traditionally tricyclic antidepressants (TCAs) have an important place in treatment of major depressive disorder (MDD). Today, often other antidepressant medications are considered as first step in the pharmacological treatment of MDD, mainly because they are associated with less adverse effects, whereby the position of TCAs appears unclear. In this study we aimed to examine the current practice of TCAs in treatment of unipolar MDD. Methods A mixed methods approach was applied. First, a selection of leading international and national guidelines was reviewed. Second, actual... Mehr ...

Verfasser: Cornelis F. Vos
Rob E. Aarnoutse
Marijke J. M. Op de Coul
Jan Spijker
Mascha M. Groothedde-Kuyvenhoven
Raluca Mihaescu
Sonja J. W. Wessels-Basten
Jordy J. E. Rovers
Sophie E. ter Hark
Aart H. Schene
Marlies E. J. L. Hulscher
Joost G. E. Janzing
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: BMC Psychiatry, Vol 21, Iss 1, Pp 1-11 (2021)
Verlag/Hrsg.: BMC
Schlagwörter: Antidepressant agents / Clinical practice guidelines / Qualitative approach / Major depressive disorder / Tricyclic antidepressants / Psychiatry / RC435-571
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29173250
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1186/s12888-021-03490-x